{{chembox
| Watchedfields = changed
| verifiedrevid = 437142907
| ImageFile = Dimiracetam.svg
| ImageName = Chemical structure of dimiracetam
| ImageSize=150px
| IUPACName = (''RS'')-3,6,7,7a-Tetrahydro-1''H''-pyrrolo[1,5-a]imidazole-2,5-dione
| OtherNames = 
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4AW7F70MZO
| PubChem = 65955
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59358
| InChI = 1/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)
| InChIKey = XTXXOHPHLNROBN-UHFFFAOYAX
| SMILES1 = O=C2NC1N(C(=O)CC1)C2
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 337612
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XTXXOHPHLNROBN-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo =126100-97-8
| SMILES= C1CC(=O)N2C1NC(=O)C2 }}
|Section2={{Chembox Properties
| Formula =
| C=6 | H=8 | N=2 | O=2
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section5={{Chembox Pharmacology
| AdminRoutes = 
| Bioavail = 
| Metabolism = 
| HalfLife = 
| ProteinBound =
| Excretion =
| Legal_status = 
| Legal_US = 
| Legal_UK =
| Legal_AU = 
| Legal_CA = 
| Pregnancy_category = 
| Pregnancy_AU = 
| Pregnancy_US = }}
}}

'''Dimiracetam''' is a [[nootropic]] drug of the [[racetam]] family,<ref>{{cite journal | last1 = Pinza | first1 = M | last2 = Farina | first2 = C | last3 = Cerri | first3 = A | last4 = Pfeiffer | first4 = U | last5 = Riccaboni | first5 = MT | last6 = Banfi | first6 = S | last7 = Biagetti | first7 = R | last8 = Pozzi | first8 = O | last9 = Magnani | first9 = M | last10 = Dorigotti | first10 = Luciano | title = Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo1,2-aimidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers | journal = Journal of Medicinal Chemistry | volume = 36 | issue = 26 | pages = 4214–20 | year = 1993 | pmid = 8277504 | doi=10.1021/jm00078a011| display-authors = 8 }}</ref> derivatives of which may have application in the treatment of [[neuropathic pain]].<ref>{{cite journal | last1 = Farina | first1 = C | last2 = Gagliardi | first2 = S | last3 = Ghelardini | first3 = C | last4 = Martinelli | first4 = M | last5 = Norcini | first5 = M | last6 = Parini | first6 = C | last7 = Petrillo | first7 = P | last8 = Ronzoni | first8 = S | title = Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain | journal = Bioorganic & Medicinal Chemistry | volume = 16 | issue = 6 | pages = 3224–32 | year = 2008 | pmid = 18171618 | doi = 10.1016/j.bmc.2007.12.015 }}</ref>

==References==
{{reflist}}

{{Racetams}}

[[Category:Racetams]]
[[Category:Pyrroloimidazoles]]
[[Category:Lactams]]


{{nervous-system-drug-stub}}